Radiation after surgery for early-stage oral tongue cancer
Part of Cancer clinical trials.
This trial tests whether giving radiation after surgery can lower the risk of the cancer coming back for people with oral tongue cancer that has specific high-risk features but not advanced spread. It aims to find the best treatment plan for patients with certain tumor characteristics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You had surgery to remove all visible oral tongue cancer
- Your cancer was early stage (pT1-2 or pT3 by depth) with certain risk factors like lymphovascular invasion or depth between 4 and 10 mm
- Your final surgical report shows clear margins (at least 2.2 to 3 mm, depending on growth pattern)
- You have no more than 2 lymph nodes with cancer and no spread outside the lymph node capsule
- You do not have any other active cancer or autoimmune disease that would interfere with radiation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding radiation therapy after surgery helps prevent the return of early-stage tongue cancer in patients who have certain risk factors, such as nerve invasion or poorly differentiated cells. It is for people whose cancer was limited to the front two-thirds of the tongue and was completely removed.
This trial tests a new way of giving radiation therapy along with chemotherapy and immunotherapy for advanced oral cavity cancer. It aims to improve how well the treatment works while reducing side effects.
This trial tests a new way of giving radiation along with standard chemotherapy and an immunotherapy drug for throat cancer. The goal is to see if this combination can better target the tumor, reduce side effects, and improve outcomes for patients with oropharyngeal cancer.
This study compares ways of treating early squamous cell cancer in the tonsil or the tongue base, using either radiation therapy, transoral (through-the-mouth) surgery, or both. It aims to see which approach works best while keeping cancer under control.
This trial compares two different treatments after surgery for advanced head and neck cancer (oral or oropharyngeal). It tests whether radiation therapy or continuing an immunotherapy drug (called PD-1 inhibitor) leads to better survival. This study might help you decide which follow-up treatment could be better for your situation.
This study tests whether a personalized approach to radiation therapy after surgery, guided by a special lymph node biopsy (sentinel node biopsy), can effectively treat mouth cancer while reducing side effects. It is for people whose cancer is on one side of the mouth and has not spread to the other side of the neck or beyond.
Hear when a new Oral Tongue Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.